PRTA - PROTHENA CORP PUBLIC LTD CO
9.86
0.500 5.071%
Share volume: 525,015
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$9.36
0.50
0.05%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-08-2024 | 08-08-2024 | 11-12-2024 | 02-27-2025 | 05-08-2025 | 08-04-2025 | 11-06-2025 | |
| Assets | ||||||||
| Total Assets | 623.194 M | 645.565 M | 595.254 M | 547.108 M | 495.336 M | 399.066 M | 352.628 M | |
| Current Assets | 565.868 M | 585.978 M | 534.984 M | 485.412 M | 436.173 M | 385.475 M | 339.974 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 18.004 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 18.004 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 546.512 M | 564.124 M | 519.262 M | 471.388 M | 417.935 M | 371.435 M | 330.843 M | |
| Total Non-current Assets | 57.326 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 3.672 M | 3.486 M | 3.254 M | 3.081 M | 2.871 M | 2.690 M | 2.463 M | |
| Other Assets | 3.609 M | 56.101 M | 57.016 M | 58.615 M | 56.292 M | 10.901 M | 10.191 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 623.194 M | 645.565 M | 595.254 M | 547.108 M | 495.336 M | 399.066 M | 352.628 M | |
| Total liabilities | 120.795 M | 63.648 M | 60.892 M | 60.182 M | 57.656 M | 74.735 M | 57.639 M | |
| Total current liabilities | 43.266 M | 46.744 M | 46.422 M | 48.501 M | 48.459 M | 67.807 M | 51.436 M | |
| Accounts Payable | 14.420 M | 9.286 M | 10.330 M | 7.770 M | 16.027 M | 12.198 M | 10.503 M | |
| Other liabilities | 67.405 M | 9.538 M | 8.881 M | 8.233 M | 7.575 M | 6.928 M | 6.203 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 67.405 M | 9.538 M | 8.881 M | 8.233 M | 7.575 M | 6.928 M | 6.203 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 502.399 M | 581.917 M | 534.362 M | 486.926 M | 437.680 M | 324.331 M | 294.989 M | |
| Common stock | 53.714 M | 1.567 B | 1.579 B | 1.589 B | 1.600 B | 1.613 B | 1.620 B | |
| Retained earnings | -1.052 B | -985.384 M | -1.044 B | -1.102 B | -1.163 B | -1.288 B | -1.325 B |